Ray Biotech Signs Master Services Deal With Research Institute
Ray Biotech Inc, a pioneer and industry leader of antibody and protein array technologies has signed master services pact with Banner Sun Health Research Institute of Sun City, Arizona.
As per the terms of deal, RayBiotech will provide priority services for the biochemical analysis of disease markers in biological samples.
The focus of the deal will be on the characterization of key biomarkers for the study of neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases.
The financial terms of the deal were not disclosed. RayBiotech’s President, Chief Operating Officer and co-founder, Rani Huang said, “We are excited about providing biomarker analysis services to BSHRI researchers. Banner Sun Health Research Institute is a unique world-class research organization that has outstanding tissue depository programme, clinical centre that conducts a large number of clinical trials, and research scientists who are dedicated to translational research in neurodegenerative and cardiovascular disorders.” Mr. Ray also said, “We believe that the collaboration will yield promising new opportunities facilitating early diagnosis of these devastating diseases.” BSHRI research scientists are engaged in biomarker discovery research in both Alzheimer’s and Parkinson’s diseases.
Dr. LihFen Lue said, “As we continue to strive towards a better understanding of the molecular mechanisms at early stage of these neurodegenerative diseases, we also recognize the importance of identifying proteins present in the biofluid that could be used as potential disease biomarkers. Fortunately, we have more cutting-edge tools these days to do this crucial research. Raybiotech Quantibody® array is one of these very useful tools."
RayBiotech provides a valuable biochemical platform to assess both the identity and quantity of these markers in a comprehensive high-throughput format.
Banner Sun Health Research is a nonprofit biomedical research centre. It conducts basic and translational research, clinical research, prevention and education programmes specialized in the study of normal ageing and certain age-related diseases.
Dubai's new smart neuro spinal hospital: need to know
We take a look at Dubai's new smart hospital.
What: The Neuro Spinal Hospital and Radiosurgery Centre is a new hospital featuring state-of-the-art technology for spinal, neurosurgical, neurological, orthopaedic, radiosurgery and cancer treatments. The 700 million AED hospital, (equivalent to £138 million), has 114 beds, smart patient rooms, and green spaces for patient rehabilitation, and is four times the capacity of its former premises in Jumeirah. It is also the UAE’s first hospital to have surgical robots.
Where: The hospital is located in the Dubai Science Park. Founded in 2005, Dubai Science Park is home to more than 350 companies from multinational corporations in life sciences, biotechnology and research; over 4,000 people work here each day.
Who: The UAE's Neuro Spinal Hospital and Radiosurgery Centre was first established in Jumeirah in 2002 by Dr. Abdul Karim Msaddi, as the first as the first "super-specialty" neuroscience hospital.
Why: With advanced diagnosis and robotics, the hospital will provide care across neuroscience, spine, orthopaedics and oncology for people residing in the UAE, as well as international patients.
Prof. Abdul Karim Msaddi, Chairman and Medical Director of the hospital, said: “We are proud to bring world-class healthcare services to Dubai and believe our next-generation hospital will be a game-changer for the emirate’s and the region’s medical industry.
"It will not only significantly increase the availability of specialist neuroscience and radiosurgery treatments and provide better patient care but help attract and develop local and international talent. Investing in the new centre represents our continued faith in the resilience of the region’s economy, as well as a testament to our ongoing drive towards healthcare innovation in the UAE.”